Aveo Pharmaceuticals ROE 2025

Aveo Pharmaceuticals Aktienanalyse

Šta radi Aveo Pharmaceuticals?

Aveo Pharmaceuticals Inc. is a bio-pharmaceutical company focused on the development of new therapies for cancer patients. The company was founded in 2001 in Cambridge, Massachusetts and is listed on the NASDAQ stock exchange under the ticker symbol AVEO. The history of Aveo Pharmaceuticals began with the discovery of a growth factor responsible for the formation of blood vessels in tumors. In collaboration with Harvard Medical School and the Dana-Farber Cancer Institute, the company developed a new drug called Tivozanib, which can block this growth factor. Tivozanib has been tested as a potential treatment for various types of cancer, including kidney cancer, breast cancer, and lung cancer, and is currently in various stages of development. Aveo Pharmaceuticals employs a collaborative business model to involve scientists and researchers in the development of new therapies. The company works together with leading academic institutions and bio-pharmaceutical companies to accelerate and improve the drug development process. Aveo Pharmaceuticals is divided into different divisions that focus on the development of therapies for different types of cancer. These divisions include oncology, which focuses on the development of therapies for solid tumors, as well as hematology, which focuses on the development of therapies for blood cancer. Aveo Pharmaceuticals also has a pipeline of products in various stages of development. These products include both novel drugs and therapies that are already on the market. One of Aveo Pharmaceuticals' most promising products is the drug Tivozanib. Tivozanib is a kinase inhibitor specifically designed for the treatment of kidney cancer. The drug has proven to be effective in clinical trials and could soon be approved by the U.S. Food and Drug Administration (FDA). Tivozanib could improve both the quality of life and the survival rate of kidney cancer patients. Another promising drug from Aveo Pharmaceuticals is Ficlatuzumab, a drug specifically designed for the treatment of solid tumors. Ficlatuzumab targets the hepatocyte growth factor receptor (HGFR), which is overexpressed in various types of cancer such as breast cancer, lung cancer, and pancreatic cancer. The drug is currently in clinical trials and has the potential to become a new treatment option for cancer patients. Over the years, Aveo Pharmaceuticals has received numerous awards and recognitions, including being recognized as one of the "50 Most Innovative Companies in the World" by Technology Review and being included in the "Forbes 200 Best Small Companies in America" ranking. In summary, Aveo Pharmaceuticals is an innovative bio-pharmaceutical company focused on the development of vital therapies for cancer patients. Aveo Pharmaceuticals' collaborative business model has enabled the company to work closely with leading academic institutions and bio-pharmaceutical companies to develop new drugs that could improve the lives of cancer patients. With Tivozanib and Ficlatuzumab, Aveo Pharmaceuticals has two promising drugs in the pipeline that have the potential to change the face of cancer treatment. Aveo Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE у детаљу

Razjašnjenje povrata na sopstveni kapital (ROE) kompanije Aveo Pharmaceuticals

Povraćaj na sopstveni kapital (ROE) kompanije Aveo Pharmaceuticals je osnovni pokazatelj koji ocenjuje profitabilnost kompanije u odnosu na sopstveni kapital. ROE, izračunat deljenjem neto dobiti sa sopstvenim kapitalom akcionara, ilustruje efikasnost kompanije u ostvarivanju profita iz investicija akcionara. Viši ROE označava povećanu efikasnost i profitabilnost.

Poređenje iz godine u godinu

Analiza ROE kompanije Aveo Pharmaceuticals iz godine u godinu pomaže u praćenju trendova profitabilnosti i finansijskih performansi. Rastući ROE ukazuje na povećanu profitabilnost i stvaranje vrednosti za akcionare, dok opadajući ROE može ukazivati na probleme u stvaranju dobiti ili upravljanju sopstvenim kapitalom.

Uticaj na investicije

ROE kompanije Aveo Pharmaceuticals je ključan za investitore koji ocenjuju profitabilnost, efikasnost i privlačnost kompanije kao investicije. Robusni ROE ukazuje na sposobnost kompanije da pretvori investicije sopstvenog kapitala u profit, čime povećava svoju privlačnost potencijalnim i sadašnjim investitorima.

Interpretacija fluktuacija ROE

Promene u ROE kompanije Aveo Pharmaceuticals mogu proizaći iz fluktuacija neto dobiti, sopstvenog kapitala ili oboje. Ove fluktuacije se analiziraju sa ciljem procene efikasnosti menadžmenta, finansijskih strategija, kao i povezanih rizika i mogućnosti, te pomažu investitorima u donošenju obrazloženih odluka.

Često postavljana pitanja o Aveo Pharmaceuticals akciji

Koliki je ROE (Return on Equity) kompanije Aveo Pharmaceuticals ove godine?

ROE kompanije Aveo Pharmaceuticals u ovoj godini iznosi 0 undefined.

Kako se ROE (Return on Equity) kompanije Aveo Pharmaceuticals razvio u poređenju sa prethodnom godinom?

ROE kompanije Aveo Pharmaceuticals se u poređenju sa prošlom godinom promenio za 0% pao.

Kakav uticaj visoki ROE (povraćaj na kapital) ima na investitore Aveo Pharmaceuticals?

Visok ROE pokazuje da Aveo Pharmaceuticals postiže dobar povraćaj kapitala i da je uspešan u monetizaciji svojih investicija. Ovo je za investitore pozitivan indikator.

Koji uticaj ima nizak ROE (Povraćaj na kapital) na investitore Aveo Pharmaceuticals?

Nizak ROE može ukazivati na to da Aveo Pharmaceuticals ima poteškoće u uspešnom monetizovanju svojih investicija i može biti negativan signal za investitore.

Kako promena ROE (Return on Equity) od Aveo Pharmaceuticals utiče na preduzeće?

Promena ROE (povraćaja na kapital) od Aveo Pharmaceuticals može biti indikator finansijske performanse kompanije i pokazati koliko je uspešna u odnosu na druge kompanije u istoj industriji.

Kako se izračunava ROE (Povraćaj na sopstveni kapital) od Aveo Pharmaceuticals?

ROE (Return on Equity) se izračunava tako što se dobit preduzeća podeli sa ukupnim kapitalom. Formula glasi: ROE = Dobit / Ukupni kapital.

Koji faktori utiču na ROE (Return on Equity) kompanije Aveo Pharmaceuticals?

Neki faktori koji mogu uticati na ROE (Return on Equity) kompanije Aveo Pharmaceuticals uključuju, između ostalih, efikasnost u korišćenju sopstvenog kapitala, profitabilnost preduzeća i strukturu finansiranja.

Koje strateške mere može preduzeti da poboljša ROE (povrat na kapital)?

Da bi poboljšao ROE (Return on Equity), može preduzeti različite mere kao što su smanjenje troškova, povećanje prihoda, poboljšanje efikasnosti korišćenja kapitala i promene u strukturi finansiranja. Važno je da kompanija izvrši temeljnu proveru svoje finansijske situacije kako bi odredila najbolje strateške mere za poboljšanje ROE (Return on Equity).

Kolika je dividenda koju isplaćuje Aveo Pharmaceuticals?

U poslednjih 12 meseci, Aveo Pharmaceuticals je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Aveo Pharmaceuticals će verovatno isplatiti dividendu od 0 USD.

Kolika je dividendna prinosa za Aveo Pharmaceuticals?

Dividendski prinos od Aveo Pharmaceuticals trenutno iznosi .

Kada Aveo Pharmaceuticals isplaćuje dividendu?

Aveo Pharmaceuticals isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Koliko je sigurna dividenda od Aveo Pharmaceuticals?

Aveo Pharmaceuticals je isplaćivao dividendu svake godine u poslednjih 0 godina.

Kolika je dividenda kompanije Aveo Pharmaceuticals?

Za narednih 12 meseci očekuju se dividende u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

U kom sektoru se nalazi Aveo Pharmaceuticals?

Aveo Pharmaceuticals se svrstava u sektor 'Zdravlje'.

Wann musste ich die Aktien von Aveo Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

Da biste primili poslednju dividendu od Aveo Pharmaceuticals od 4. 8. 2025. u iznosu od 0 USD, morali ste da imate akciju u depou pre Ex-dana 4. 8. 2025..

Kada je Aveo Pharmaceuticals poslednji put isplatio dividendu?

Isplata poslednje dividende izvršena je 4. 8. 2025..

Kolika je bila dividenda od Aveo Pharmaceuticals u godini 2024?

U godini 2024 kompanija Aveo Pharmaceuticals je isplatila 0 USD kao dividende.

U kojoj valuti Aveo Pharmaceuticals isplaćuje dividendu?

Dividende od Aveo Pharmaceuticals se isplaćuju u USD.